Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2'-deoxyadenosine, 2'-deoxyguanosine and their analogs

Biochimie

Volumn 81, Issue 11, 1999, Pages 1041-1047

  Gaubert, Gilles ^a   Gosselin, Gilles ^a   Boudou, Valérie ^a   Imbach, Jean Louis ^a   Eriksson, Staffan ^b   Maury, Georges ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Deoxycytidine kinase; Deoxyguanosine kinase; Enantioselectivity; L nucleoside analogs; Substrate properties

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE; DEOXYADENOSINE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE; DEOXYGUANOSINE KINASE; GUANOSINE DERIVATIVE; NUCLEOSIDE ANALOG;

ANTIVIRAL ACTIVITY; ARTICLE; ENANTIOMER; ENZYME SUBSTRATE; HUMAN; PHOSPHORYLATION;

EID: 0032738846     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)00331-4     Document Type: Article

References (47)

1. Secrist J.A. III, Montgomery J.A., Shealy Y.F., O'Dell C.A., Clayton S.J. Resolution of racemic carbocyclic analogues of purine nucleosides through the action of adenosine deaminase. Antiviral activity of the carbocyclic 2'-deoxyguanosine enantiomers. J. Med. Chem. 30:1987;746-749.
2. Mahmoudian M., Baines B.S., Drake C.S., Hale R.S., Jones P., Piercey J.E., Montgomery D.S., Purvis I.J., Storer R., Dawson M.J., Lawrence J.C. Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, Lamivudine): A potent anti-HIV agent. Enzyme Microb. Technol. 15:1993;749-755.
3. Furman P.A., Wilson J.E., Reardon J.E., Painter G.R. The effect of absolute configuration on the anti-HIV and anti-HBV activity of nucleoside analogues. Antiviral Chem. Chemother. 6:1995;345-355.
4. Chang C.N., Doong S.L., Zhou J.H.C., Beach J.W., Jeong L.S., Chu C.K., Tsai C., Cheng Y.C. Deoxycytidine deaminase resistant stereoisomer is the active form of (±)-2', 3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication. J. Biol. Chem. 267:1992;13938-13942.
5. Gosselin G., Schinazi R.F., Sommadossi J.P., Mathé C., Bergogne M.C., Aubertin A.M., Kirn A., Imbach J.L. Anti-human immunodeficiency virus activities of the β-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrob. Agents Chemother. 38:1994;1292-1297.
6. Schinazi R.F., Gosselin G., Faraj A., Korba B.E., Liotta D.C., Chu C.K., Mathé C., Imbach J.L., Sommadossi J.P. Pure nucleoside enantiomers of β-2',3'-dideoxycytidine analogues are selective inhibitors of hepatitis B virus in vitro. Antimicrob. Agents Chemother. 38:1994;2172-2174.
7. VanDraanen N.A., Tisdale M., Parry N.R., Jansen R., Dorsife R.E., Tuttle J.V., Averett D.R., Koszalka G.W. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. Antimicrob. Agents Chemother. 38:1994;868-871.
8. Martin L.T., Faraj A., Schinazi R.F., Gosselin G., Mathé C., Imbach J.L., Sommadossi J.P. Effect of stereoisomerism on the cellular pharmacology of β-enantiomers of cytidine analogs in Hep-G2 cells. Biochem. Pharmacol. 53:1997;75-87.
9. Dutschman G.E., Bridges E.G., Liu S.H., Gullen E., Guo X., Kukhanova M., Cheng Y.C. 2',3'-Dideoxy-2',3'-didehydro-β-L (-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus β-D (+) nucleoside analogs in vitro. Antimicrob. Agents Chemother. 42:1998;1799-1804.
10. Grove K.L., Guo X., Liu S.H., Gao Z., Chu C.K., Cheng Y.C. Anticancer activity of β-L-dioxolanecytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res. 55:1995;3008-3011.
11. Spadari S., Maga G., Verri A., Bendiscioli A., Tondelli L., Capobianco M., Colonna F., Garbesi A., Focher F. Lack of stereospecificity of some cellular and viral enzymes involved in the synthesis of deoxyribonucleotides and DNA: molecular basis for the antiviral activity of unnatural L-β-nucleosides. Biochimie. 77:1995;861-867.
12. Pai S.B., Liu S.H., Zhu Y.L., Chu C.K., Cheng Y.C. Inhibition of hepatitis B virus by a novel L-nucleoside 2'-fluoro-5-methyl-β-L-arabinofuranosyl uracil. Antimicrob. Agents Chemother. 40:1996;380-386.
13. Yao G.Q., Liu S.H., Chou E., Kukhanova M., Chu C.K., Cheng Y.C. Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2'-fluoro-5-methyl-β-L-arabinofuranosyluracil. Biochem. Pharmacol. 51:1996;941-947.
14. Elaoui A.M., Faraj A., Pierra C., Boudou V., Johnson R., Mathé C., Gosselin G., Korba B.E., Imbach J.L., Schinazi R.F., Sommadossi J.P. Inhibition of hepatitis B virus replication by nucleoside enantiomers of β-2',3'-dideoxypurine analogues. Antiviral. Chem. Chemother. 7:1996;276-280.
15. Arner E.S.J., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67:1995;155-186.
16. Spadari S., Maga G., Focher F., Ciarrocchi G., Manservigi R., Arcamone F., Capobianco M., Carcuro A., Colonna F., Jotti S., Garbesi A. L-Thymidine is phosphorylated by Herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J. Med. Chem. 35:1992;4214-4220.
17. Chang C.N., Skalski V., Zhou J.H., Cheng Y.C. Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents. J. Biol. Chem. 267:1992;22414-22420.
18. Shewach D.S., Liotta D.C., Schinazi R.F. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase. Biochem. Pharmacol. 45:1993;1540-1543.
19. Verri A., Focher F., Priori G., Gosselin G., Imbach J.L., Capobianco M., Garbesi A., Spadari S. Lack of enantioselectivity of human 2'-deoxycytidine kinase: relevance for the activation of β-L-deoxycytidine analogs as antineoplastic and antiviral agents. Mol. Pharmacol. 51:1997;132-138.
20. Shafiee M., Griffon J.F., Gosselin G., Cambi A., Vincenzetti S., Vita A., Eriksson S., Imbach J.L., Maury G. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase. Biochem. Pharmacol. 56:1998;1237-1242.
21. Tomikawa A., Kohgo S., Ikezawa H., Iwanami N., Shudo K., Kawaguchi T., Saneyoshi M., Yamaguchi T. Chiral discrimination of 2'-deoxy-L-cytidine and L-nucleosides by mouse deoxycytidine kinase: low stereospecificities for substrates and effectors. Biochem. Biophys. Res. Commun. 239:1997;329-333.
22. Verri A., Priori G., Spadari S., Tondelli L., Focher F. Relaxed enantioselectivity of human mitochondrial thymidine kinase and chemotherapeutic uses of L-nucleoside analogues. Biochem. J. 328:1997;317-320.
23. Wang J., Chattopadhyaya J., Eriksson S. The enantioselectivities of the cellular deoxynucleoside kinases. Nucleosides Nucleotides. 18:1999;807-810.
24. Bennett L.L., Allan P.W., Arnett G., Shealy Y.F., Shewach D.S., Mason W.S., Fourel I., Parker W.P. Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase and 5'-nucleotidase. Antimicrob. Agents Chemother. 42:1998;1045-1051.
25. Pelicano H., Pierra C., Eriksson S., Gosselin G., Imbach J.L., Maury G. Enzymatic properties of the unnatural β-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine. J. Med. Chem. 40:1997;3969-3973.
26. Eriksson S., Wang L. Substrate specificities, expression and primary sequences of deoxynucleoside kinases; implications for chemotherapy. Nucleosides Nucleotides. 16:1997;653-659.
27. Boudou V. 1997;PhD Dissertation, University Montpellier-2.
28. Bolon P.J., Wang P., Chu C.K., Gosselin G., Boudou V., Pierra C., Mathé C., Imbach J.L., Faraj A., ElAlaoui M.A., Sommadossi J.P., Pai S.B., Zhu Y.L., Cheng Y.C., Schinazi R.F. Anti-human immunodeficiency and anti-hepatitis B virus activities of β-L-2',3'-dideoxy purine nucleosides. Bioorg. Med. Chem. Lett. 6:1996;1657-1662.
29. Gosselin G., Bergogne M.C., Imbach J.L. Synthesis and antiviral evaluation of β-L-xylofuranosyl nucleosides of the five naturally occurring nucleic acid bases. J. Heterocyclic Chem. 30:1993;1229-1233.
30. Robins M.J., Zou R., Guo Z., Wnuk S.F. Nucleic acid related compounds. A solution to the historic problem of regioselective sugar-base coupling to produce 9-glycosylguanines or 7-glycosylguanines. J. Org. Chem. 61:1996;9207-9212.
31. Chottinger E.G., Shewach D.S., Datta N.S., Ashcraft E., Gribbin D., Ginsburg D., Fox I.H., Mitchell B.S. Cloning and expression of human deoxycytidine kinase cDNA. Proc. Natl. Acad. Sci. USA. 88:1991;1531-1535.
32. Johansson N.G., Eriksson S. Structure activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Acta Biochim. Pol. 43:1996;143-160.
33. Sjoberg A.H., Wang L., Eriksson S. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. Mol. Pharmacol. 53:1998;270-273.
34. Johanson M., Karlsson A. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinases. Biochem. Pharmacol. 50:1995;163-168.
35. Zhu C., Johansson M., Permert J., Karlsson A. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase. Biochem. Pharmacol. 56:1998;1035-1040.
36. Chen C., Fujimoto Y., Girkaudas G., Sih C.J. Quantitative analyses of biochemical kinetic resolutions of enantiomers. J. Am. Chem. Soc. 104:1982;7294-7299.
37. Sarup J.C., Fridland A. Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides. Biochemistry. 26:1987;590-597.
38. Usova E., Eriksson S. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase. Eur. J. Biochem. 248:1997;762-766.
39. Ruiz vanHaperen V.W.T., Veerman G., Vermorken J.B., Pinedo H.M., Peters G.J. Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (Gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine. Biochem. Pharmacol. 51:1996;911-918.
40. Kierdaszuk B., Rigler R., Eriksson S. Binding of substrates to human deoxycytidine kinase studied with ligand-dependent quenching of enzyme intrinsic fluorescence. Biochemistry. 32:1993;699-707.
41. Shafiee M., Gosselin G., Imbach J.L., Divita G., Eriksson S., Maury G. Study of human deoxycytidine kinase binding properties using intrinsic fluorescence or new fluorescent ligands. Eur. J. Med. Chem. 34:1999;423-431.
42. Eriksson S., Kierdaszuk B., Munch-Petersen B., Oberg B., Johansson N.G. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem. Biophys. Res. Commun. 176:1991;586-592.
43. Krenitsky T.A., Tuttle J.V., Koszalka G.W., Chen I.S., Beacham III L.M., Rideout J.L., Elion G.B. Deoxycytidine kinase from calf thymus. J. Biol. Chem. 251:1976;4055-4061.
44. Wang L., Hellman U., Eriksson S. Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA. FEBS Lett. 390:1996;39-43.
45. Harrison P.T., Thompson R., Davison A.J. Evolution of Herpes virus thymidine kinases from cellular deoxycytidine kinase. J. Gen. Virol. 72:1991;2583-2586.
46. Wild K., Bohner T., Aubry A., Folkers G., Schulz G.E. The three-dimentional structure of thymidine kinase from Herpes simplex virus type 1. FEBS Lett. 368:1995;289-292.
47. Brown D.G., Visse R., Sandhu G., Davies A., Rizkallah P.J., Melitz C., Summers W.C., Sanderson M.R. Crystal structures of the thymidine kinase from Herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir. Nature Struct. Biol. 2:1995;876-881.